WhiteBook2_Part2 - 38

Appendix
Czech Society of Gastroenterology
Develop new capacities to
reduce burden
Develop new capacities to
reduce burden
Develop new capacities to
reduce burden
Improve performance of existing
capacities to reduce burden
Improve performance of existing
capacities to reduce burden
Diagnosis
Drug therapy
Microbiology
Health care
quality, access,
and evaluation
Information
science
Drug therapy
Malignant neoplasms of
digestive organs (C15-C26)
Crohn's disease and
ulcerative colitis (K50-K51)
All diseases of the digestive
system (K20-K93)
All diseases of the digestive
system (K20-K93)
Malignant neoplasms of
digestive organs (C15-C26)
Viral hepatitis (B15-B19)
Screening-Surveillance of
pancreatic (biliary)
malignancies
Implementation of
personalized treatment in IBD
patients
Defining of a " healthy "
microbiome, and its changes
Guidelines and quality
indicators in gastroenterology
Hi-tech endoscopic imaging and
artificial intelligence
Egyptian Association for Research and Training in Hepato-Gastroenterology
Assess burden of disease and its
determinants
Assess burden of disease and its
determinants
Improve performance of existing
capacities to reduce burden
Epidemiology
Drug therapy
Crohn's disease and
ulcerative colitis (K50-K51)
Gastritis, dyspepsia and
other diseases of stomach
and duodenum (K29-K31)
Georgian National Society of Gastroenterology and Hepatology
Assess burden of disease and its
determinants
Metabolism
Improve performance of existing
capacities to reduce burden
Develop new capacities to
reduce burden
Develop new capacities to
reduce burden
Develop new capacities to
reduce burden
Develop new capacities to
reduce burden
Improve performance of existing
capacities to reduce burden
Assess burden of disease and its
determinants
Improve performance of existing
capacities to reduce burden
Diagnosis
German Society of Gastroenterology (DGVS)
Drug therapy
Pathology and
physiopathology
Prevention and
control
Prevention and
control
Diet therapy
Hellenic Society of Gastroenterology
Drug therapy
Surgical
procedures,
operative
Gastritis, dyspepsia and
other diseases of stomach
and duodenum (K29-K31)
Other diseases of the
digestive system (K90.1K93)
H,
pylori eradication schemes
Sedation in endoscopy
Crohn's disease and
ulcerative colitis (K50-K51)
Diseases of pancreas (K85K86,
K87.1)
Malignant neoplasms of
digestive organs (C15-C26)
Other diseases of liver (K71K77)
Irritable
bowel syndrome
(K58)
Challenge: therapy
management based on
biomarkers
Basic research guiding novel
therapies for inflamm. & cancer
Based on new immunologic /
metabolic mechanisms
Risk assessment and screening
Neurogastroenterology from
basic to clinic
Other diseases of liver (K71K77)
Crohn's
disease and
ulcerative colitis (K50-K51)
Analyzing the large program for
managing viral hepatitis
Characteristics of IBD in Egypt
H. Pylori infection
Our Society is interested in
scientific-clinical research
Our Society is interested in
microbiota during IBD
White Book 2: Part 2
35
WhiteBook2_Part2

Table of Contents for the Digital Edition of WhiteBook2_Part2
